NBUVB: narrowband ultraviolet B; TCI: topical calcineurin inhibitor; TCS: topical corticosteroid.
* Trigger/exacerbating factors:¶ Mild atopic dermatitis – Areas of dry skin, infrequent itching (with or without small areas of redness); little impact on everyday activities, sleep, and psychosocial wellbeing.
Δ Moderate atopic dermatitis – Areas of dry skin, frequent itching, redness (with or without excoriation and localized skin thickening); moderate impact on everyday activities and psychosocial wellbeing, frequently disturbed sleep.
◊ Severe atopic dermatitis – Widespread areas of dry skin, incessant itching, redness (with or without excoriation, extensive skin thickening, bleeding, oozing, cracking, and alteration of pigmentation); severe limitation of everyday activities and psychosocial functioning, nightly loss of sleep.
§ Crisaborole is approved for mild to moderate atopic dermatitis in adults and children >3 months.
¥ TCIs are approved for mild to moderate atopic dermatitis in adults and children >2 years. TCIs include tacrolimus and pimecrolimus.آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟